Merck to pay $950m to settle Vioxx charges

Merck became the second major pharma company to agree to a large settlement with the federal government this week.

Merck became the second major pharma company to agree to a large settlement with the federal government this week. The company will reportedly pay $950 million to settle charges that it promoted painkiller Vioxx for an unapproved use.

Earlier this week, The Wall Street Journal reported that Pfizer will pay more than $60 million to resolve government investigations into whether it paid bribes to win foreign business.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.